Literature DB >> 22172990

Bismuth ions inhibit the biological activity of non-amidated gastrins in vivo.

Suzana Kovac1, Su-Wen Loh, Shamilah Lachal, Arthur Shulkes, Graham S Baldwin.   

Abstract

The peptide hormone gastrin binds two ferric ions with high affinity, and iron binding is essential for the biological activity of non-amidated gastrins in vitro and in vivo. Bi3+ ions also bind to glycine-extended gastrin17 (Ggly), but inhibit Ggly-induced cell proliferation and migration in gastrointestinal cell lines in vitro. The aims of the present study were firstly, to establish the mechanism by which Bi3+ ions inhibit the binding of Fe3+ ions to Ggly, and secondly, to test the effect of Bi3+ ions on the activity of non-amidated gastrins in vivo. The interaction between Bi3+ ions, Fe3+ ions and Ggly was investigated by ultraviolet spectroscopy. The effect of Bi3+ ions on colorectal mucosal proliferation was measured in three animal models. In vitro in the presence of Bi3+ ions the affinity of Fe3+ ions for Ggly was substantially reduced; the data was better fitted by a mixed, rather than a competitive, inhibition model. In rats treated with Ggly alone proliferation in the rectal mucosa was increased by 318%, but was reduced to control values (p < 0.001) in animals receiving oral bismuth plus Ggly. Proliferation in the colonic mucosa of mice overexpressing Ggly or progastrin was significantly greater than in wild-type mice, but was no greater than control (p < 0.01) in animals receiving oral bismuth. Thus a reduction in the binding of Fe3+ ions to Ggly and progastrin in the presence of Bi3+ ions is a likely explanation for the ability of oral bismuth to block the biological activity of non-amidated gastrins in vivo.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172990      PMCID: PMC3259252          DOI: 10.1016/j.bcp.2011.11.030

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  34 in total

1.  Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation.

Authors:  T J Koh; G J Dockray; A Varro; R J Cahill; C A Dangler; J G Fox; T C Wang
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  A graphical user interface for BIOEQS: a program for simulating and analyzing complex biomolecular interactions.

Authors:  Tilman Rosales; Catherine A Royer
Journal:  Anal Biochem       Date:  2008-06-24       Impact factor: 3.365

3.  Processing and proliferative effects of human progastrin in transgenic mice.

Authors:  T C Wang; T J Koh; A Varro; R J Cahill; C A Dangler; J G Fox; G J Dockray
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

4.  Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells.

Authors:  P Singh; H Wu; C Clark; A Owlia
Journal:  Oncogene       Date:  2006-07-10       Impact factor: 9.867

Review 5.  The actions of bismuth in the treatment of Helicobacter pylori infection.

Authors:  J R Lambert; P Midolo
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

6.  Stimulation of proliferation in the colorectal mucosa by gastrin precursors is blocked by desferrioxamine.

Authors:  Audrey Ferrand; Shamilah Lachal; Gianni Bramante; Suzana Kovac; Arthur Shulkes; Graham S Baldwin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-15       Impact factor: 4.052

Review 7.  Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.

Authors:  Pomila Singh
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

Review 8.  Gastrin and cancer: a review.

Authors:  Audrey Ferrand; Timothy C Wang
Journal:  Cancer Lett       Date:  2005-07-27       Impact factor: 8.679

Review 9.  Gastrin - active participant or bystander in gastric carcinogenesis?

Authors:  Susan A Watson; Anna M Grabowska; Mohamad El-Zaatari; Arjun Takhar
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

10.  Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis.

Authors:  K D Fine; E L Lee
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

View more
  4 in total

1.  Complexes of gastrin with In3+, Ru3+ or Ga3+ ions are not recognised by the cholecystokinin 2 receptor.

Authors:  Marie Laval; Kathryn M Marshall; John Sachinidis; Andrew Scott; Mal Eutick; Graham S Baldwin
Journal:  J Biol Inorg Chem       Date:  2017-07-12       Impact factor: 3.358

2.  Tyrosine modification increases the affinity of gastrin for ferric ions.

Authors:  Graham S Baldwin; Ioulia Sims
Journal:  Springerplus       Date:  2015-12-24

Review 3.  The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults.

Authors:  Carmen Alonso-Cotoner; Mar Abril-Gil; Mercé Albert-Bayo; John-P Ganda Mall; Elba Expósito; Ana M González-Castro; Beatriz Lobo; Javier Santos
Journal:  Adv Ther       Date:  2021-03-18       Impact factor: 3.845

4.  High Affinity Binding of Indium and Ruthenium Ions by Gastrins.

Authors:  Graham S Baldwin; Graham N George; M Jake Pushie
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.